Results 41 to 50 of about 141,658 (207)

Liver: Intrahepatic cholangiocarcinoma [PDF]

open access: yes, 2009
Review on Liver: Intrahepatic cholangiocarcinoma, with data on clinics, and the genes ...
Aishima, S, Enjoji, M
core   +1 more source

Fifteen years of clinical liver transplantation [PDF]

open access: yes, 1979
Liver transplantation in humans was first attempted more than 15 yr ago. The 1-yr survival has slowly improved until it has now reached about 50%. In our experience, 46 patients have lived for at least 1 yr, with the longest survival being 9 yr. The high
Abouna   +65 more
core   +1 more source

Cordycepin Induces S Phase Arrest and Apoptosis in Human Gallbladder Cancer Cells

open access: yesMolecules, 2014
Gallbladder cancer is the most common malignant tumor of the biliary tract, and this condition has a rather dismal prognosis, with an extremely low five-year survival rate.
Xu-An Wang   +18 more
doaj   +1 more source

Application progress of CT radiomics in gastrointestinal stromal tumor

open access: yesShanghai Jiaotong Daxue xuebao. Yixue ban, 2023
Gastrointestinal stromal tumor (GIST) is the most common mesenchymal tumor in the gastrointestinal tract, with complex biological characteristics and varying risks, and the treatment methods and prognosis of patients with different risks are quite ...
MA Ben, ZHAO Cheng, SHU Yijun, DONG Ping
doaj   +1 more source

Pathologic analysis of liver transplantation for primary biliary cirrhosis [PDF]

open access: yes, 1988
A retrospective histopathologic review of all pathologic specimens from 394 adult liver transplant patients was undertaken with clinical correlation to determine if primary biliary cirrhosis has affected the posttrans‐plant course compared to all other ...
Ballardini   +25 more
core   +1 more source

Recent Advancements in Known and Emerging Risk Factors of Hepatocellular Carcinoma

open access: yesCancer Medicine
Background Hepatocellular carcinoma (HCC) is the most common primary liver malignancy and a leading cause of cancer‐related deaths worldwide. Despite advancements in antiviral therapies for hepatitis B (HBV) and hepatitis C (HCV), HCC incidence continues
Muhammad Masroor Hussain   +5 more
doaj   +1 more source

Is conventional functional liver remnant volume higher than 40% still sufficient to prevent post‐hepatectomy liver failure in jaundiced patients with hilar cholangiocarcinoma? A single‐center experience in China

open access: yesCancer Medicine
Objective Our study aims to evaluate the predictive accuracy of functional liver remnant volume (FLRV) in post‐hepatectomy liver failure (PHLF) among surgically‐treated jaundiced patients with hilar cholangiocarcinoma (HCCA).
Tian‐Run Lv   +5 more
doaj   +1 more source

Integrating bulk and single cell sequencing data to identify prognostic biomarkers and drug candidates in HBV associated hepatocellular carcinoma

open access: yesScientific Reports
Hepatitis B virus (HBV) infection is a major driver of hepatocellular carcinoma (HCC), yet the mechanisms by which HBV triggers HCC and how it interacts with the immune system remain largely undefined.
Yanjie Zhong   +8 more
doaj   +1 more source

Improved long‐term outcomes after innovative preoperative evaluation and conception of precise surgery for gallbladder cancer

open access: yesCancer Medicine, 2023
Background Three‐dimensional visualization preoperative evaluation (3D‐VPE) and enhanced recovery after surgery (ERAS) have been suggested to improve outcomes of cancer surgery in patients, yet little is known regarding their clinical benefit in patients
Zi‐Yao Jia   +20 more
doaj   +1 more source

SEMS vs cSEMS in duodenal and small bowel obstruction : high risk of migration in the covered stent group [PDF]

open access: yes, 2013
Aim: To compare clinical success and complications of uncovered self-expanding metal stents (SEMS) vs covered SEMS (cSEMS) in obstruction of the small bowel.
Albert, Jörg Gerhard   +7 more
core   +1 more source

Home - About - Disclaimer - Privacy